Enacademic 🎓Analogindex
49 subscribers
77.3K photos
5 videos
249K links
Download Telegram
*Почему люди охотно пересылают страшилки в мессенджерах и как отличить правду от вымысла*

Это происходит не из-за глупости.
[Read more...](https://lifehacker.ru/strashilki-v-messendzherax/)
*Cathie Wood sinks nearly $2 million into falling tech stock*

Cathie Wood, CEO and investment lead of Ark Invest, loves her disruptive tech stocks. While a prominent aspect of Ark’s funds is made up of more traditional tech names, such as Tesla TSLA, the firm has snapped up plenty of shares in biotechnology companies over the years. Ark bought a total of 268,772 shares of Pacific Biosciences PACB on Nov. 7. The bulk of this purchase was made by Ark’s Innovation ETF. The firm also purchased a total of 468,261 shares of Ginkgo Bioworks DNA and 13,596 shares of 10x Genomics TXG – Ark Innovation carried the bulk of these purchases as well. After reaching a 52-week-high of $14.05 in July, PacBio’s stock has been on the decline. The company’s shares are down nearly 20% for the year, closing Nov. 7 at $6.88. Reporting third-quarter results in October, the company noted a net loss of 26 cents per share, below the loss of 34 cents per share it reported in the year-ago period. Also, the company reported revenue of $55.7 million for the quarter, a 72% year-over-year increase. Related: Cathie Wood snaps up $5 million in one disruptive tech stock "PacBio had another successful quarter as we continued to drive Revio adoption and exceeded $50 million in quarterly revenue for the first time in company history," Christian Henry, president and CEO of PacBio said in a statement at the time. Analysts have rated the company a moderate buy. Also, according to its Piotroski F-Score, which rates a company’s financial health from 0-9, PacBio has a score of three. Ark Innovation’s holding in PacBio, worth just under $130 million, makes up 1.78% of the fund. Ginkgo, which reports earnings after the bell Nov. 8, closed the previous session at $1.54 per share. The company’s stock is down 11% for the year. For 10x Genomics, its stock is up a little more than 3% for the year, and it closed the previous session at $39.02. Since the summer of 2022, Wood has been purchasing biotech stocks en masse. In a 2021 interview with CNBC, Ark Invest analyst Simon Barnett said that Ark sees genomics as “one of the most transformative investment opportunities of the century.”
[Read more...](https://www.thestreet.com/investing/cathie-wood-sinks-nearly-2-million-into-falling-tech-stock)
Cathie Wood sinks nearly $2 million into falling tech stock

Cathie Wood, CEO and investment lead of Ark Invest, loves her disruptive tech stocks. While a prominent aspect of Ark’s funds is made up of more traditional tech names, such as Tesla TSLA, the firm has snapped up plenty of shares in biotechnology companies over the years. Ark bought a total of 268,772 shares of Pacific Biosciences PACB on Nov. 7. The bulk of this purchase was made by Ark’s Innovation ETF. The firm also purchased a total of 468,261 shares of Ginkgo Bioworks DNA and 13,596 shares of 10x Genomics TXG – Ark Innovation carried the bulk of these purchases as well. After reaching a 52-week-high of $14.05 in July, PacBio’s stock has been on the decline. The company’s shares are down nearly 20% for the year, closing Nov. 7 at $6.88. Reporting third-quarter results in October, the company noted a net loss of 26 cents per share, below the loss of 34 cents per share it reported in the year-ago period. Also, the company reported revenue of $55.7 million for the quarter, a 72% year-over-year increase. Related: Cathie Wood snaps up $5 million in one disruptive tech stock "PacBio had another successful quarter as we continued to drive Revio adoption and exceeded $50 million in quarterly revenue for the first time in company history," Christian Henry, president and CEO of PacBio said in a statement at the time. Analysts have rated the company a moderate buy. Also, according to its Piotroski F-Score, which rates a company’s financial health from 0-9, PacBio has a score of three. Ark Innovation’s holding in PacBio, worth just under $130 million, makes up 1.78% of the fund. Ginkgo, which reports earnings after the bell Nov. 8, closed the previous session at $1.54 per share. The company’s stock is down 11% for the year. For 10x Genomics, its stock is up a little more than 3% for the year, and it closed the previous session at $39.02. Since the summer of 2022, Wood has been purchasing biotech stocks en masse. In a 2021 interview with CNBC, Ark Invest analyst Simon Barnett said that Ark sees genomics as “one of the most transformative investment opportunities of the century.”
Read more...
*Аксельбант*

via forma full 5 https://ift.tt/borGT3P Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3575917.html)
*OREO Wants to Reward You for Putting Up Holiday Decorations Early*

Decorating early could score you a fresh pile of cash … and a pile of cookies. READ MORE...
[Read more...](https://www.apartmenttherapy.com/oreo-hoa-contest-2023-37338599?utm_source=RSS&utm_medium=feed&utm_campaign=Category%2FChannel%3A+main)
*The Unexpected and Trendy Water Bottle Accessory That’ll Make Your Life So Much Easier*

Stay hydrated on the go — the convenient way. READ MORE...
[Read more...](https://www.apartmenttherapy.com/wanderfull-hydrobag-review-37338262?utm_source=RSS&utm_medium=feed&utm_campaign=Category%2FChannel%3A+main)
*Morningstar's 3 favorite dividend stocks for November*

Dividend stocks can offer a safe haven during times of market turmoil, providing regular (sometimes rising) income and the potential for capital gains. David Harrell, editor of the Morningstar Dividend Investor newsletter, has offered a trio of the firm’s favorite dividend stocks, or “three dividend stocks for November,” as he put it. Two are utility stocks that represent Morningstar’s top two picks in the sector, and the other is a cellphone-tower real estate investment trust (REIT). All three have a Morningstar moat rating of narrow, which means the firm believes they have competitive advantages that will last at least 10 years.Entergy ETR Morningstar fair value estimate: $120. Wednesday price quote: $96.05. Entergy is one of the country’s biggest power producers, with five regulated, integrated utilities in Arkansas, Louisiana, Mississippi, and Texas. It has a forward yield of 4.6%. The company left its dividend unchanged from 2010 to 2015 and then began raising the payout by about 2% each year. More recently, it provided increases of 6% in both 2021 and 2022. And last month, it declared a 5.6% rise. Morningstar analysts expect future increases to track earnings growth, which they forecast at 7% annualized over the next five years.NiSource NI Morningstar fair value estimate: $33. Wednesday price quote: $24.85. NiSource is one of the country’s largest natural gas distribution companies. It transmits and distributes electricity to 500,000 customers in northern Indiana. The company has a 3.99% forward dividend yield, with a 6.1% annualized dividend growth rate over the past five years. That rate of growth should continue, with a payout ratio of around 60%, for at least the next three years, Morningstar analysts said. The payout ratio is the dividend-per-share number divided by profit per share. While this is a higher payout ratio than many of its peers, Morningstar analysts believe that NiSource has “enough financial flexibility and constructive rate regulation” to support it. American Tower AMT Morningstar fair value estimate: $225. Wednesday price quote: $183.50. American Tower owns and operates more than 220,000 cellphone towers in the U.S., Asia, Latin America, Europe, and Africa. It also owns and operates 28 U.S. data centers. American Tower has provided strong dividend growth over the past five years, at an annualized rate of 17.5%. It has raised its dividend with almost every quarterly payout since 2012, Harrell noted. “However, Morningstar analysts expect a somewhat lower growth rate, in the low double digits annually going forward, as the REIT pays down debt,” he said. American Tower management has committed to an annualized dividend growth rate of 10%. The stock has a forward yield of 3.49%. The author of this story owns shares of American Tower.
[Read more...](https://www.thestreet.com/investing/stocks/morningstar-3-favorite-dividend-stocks-for-november)
Morningstar's 3 favorite dividend stocks for November

Dividend stocks can offer a safe haven during times of market turmoil, providing regular (sometimes rising) income and the potential for capital gains. David Harrell, editor of the Morningstar Dividend Investor newsletter, has offered a trio of the firm’s favorite dividend stocks, or “three dividend stocks for November,” as he put it. Two are utility stocks that represent Morningstar’s top two picks in the sector, and the other is a cellphone-tower real estate investment trust (REIT). All three have a Morningstar moat rating of narrow, which means the firm believes they have competitive advantages that will last at least 10 years.Entergy ETR Morningstar fair value estimate: $120. Wednesday price quote: $96.05. Entergy is one of the country’s biggest power producers, with five regulated, integrated utilities in Arkansas, Louisiana, Mississippi, and Texas. It has a forward yield of 4.6%. The company left its dividend unchanged from 2010 to 2015 and then began raising the payout by about 2% each year. More recently, it provided increases of 6% in both 2021 and 2022. And last month, it declared a 5.6% rise. Morningstar analysts expect future increases to track earnings growth, which they forecast at 7% annualized over the next five years.NiSource NI Morningstar fair value estimate: $33. Wednesday price quote: $24.85. NiSource is one of the country’s largest natural gas distribution companies. It transmits and distributes electricity to 500,000 customers in northern Indiana. The company has a 3.99% forward dividend yield, with a 6.1% annualized dividend growth rate over the past five years. That rate of growth should continue, with a payout ratio of around 60%, for at least the next three years, Morningstar analysts said. The payout ratio is the dividend-per-share number divided by profit per share. While this is a higher payout ratio than many of its peers, Morningstar analysts believe that NiSource has “enough financial flexibility and constructive rate regulation” to support it. American Tower AMT Morningstar fair value estimate: $225. Wednesday price quote: $183.50. American Tower owns and operates more than 220,000 cellphone towers in the U.S., Asia, Latin America, Europe, and Africa. It also owns and operates 28 U.S. data centers. American Tower has provided strong dividend growth over the past five years, at an annualized rate of 17.5%. It has raised its dividend with almost every quarterly payout since 2012, Harrell noted. “However, Morningstar analysts expect a somewhat lower growth rate, in the low double digits annually going forward, as the REIT pays down debt,” he said. American Tower management has committed to an annualized dividend growth rate of 10%. The stock has a forward yield of 3.49%. The author of this story owns shares of American Tower.
Read more...
*Rebel's Edge -Analyzing Market News- $TTWO, $RBLX, $UPST, and NFL Firings*

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Take2 Interactive teasing the Grand Theft Auto VI announcement, Upwork crushing earnings in every category, Unusual Option Activity the predicted today's huge pop in Roblox, and Upstart with a profound earnings miss. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about NFL head coach firings, and who won the draft. Stay on the cutting edge with Rebel's Edge. Learn more about options trading with Jon and Pete at: https://marketrebellion.com
[Read more...](https://www.thestreet.com/investing/rebels-edge-november-8)
Rebel's Edge -Analyzing Market News- $TTWO, $RBLX, $UPST, and NFL Firings

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Take2 Interactive teasing the Grand Theft Auto VI announcement, Upwork crushing earnings in every category, Unusual Option Activity the predicted today's huge pop in Roblox, and Upstart with a profound earnings miss. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about NFL head coach firings, and who won the draft. Stay on the cutting edge with Rebel's Edge. Learn more about options trading with Jon and Pete at: https://marketrebellion.com
Read more...
*Подкаст Лайфхакера: что делать, если продуло шею*

Боль в шее редко бывает опасной и в большинстве случаев проходит сама собой через несколько дней.
[Read more...](https://lifehacker.ru/lifehacker-podcast-1111/)